Senior Project Manager, Jenner Institute, University of Oxford
I studied at the University of Oxford, and have 20 years' experience in immunotherapy research, spanning academia and industry.
I worked for 12 years at Immunocore Ltd developing immunotherapeutics for cancer, and in 2013 returned to the University of Oxford where I work at the Jenner Institute, managing translational vaccine projects.
Since 2015 I have been the CSO of Ducentis Biotherapeutics Ltd, developing novel therapies for autoimmune disease and inflammation.
I am an external consultant in the fields of vaccine development including GMP manufacture, and cancer immunotherapy.
Jul 21, 2020 14:01 pm UTC| Science
A vaccine against COVID-19 is urgently needed if were to stop the virus spreading and prevent potentially millions of further deaths. Were now one step closer to that goal. Today, we published early results from our...